Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Bonds | 105.490 | 106.270 | 0.780 |
Convertible | 0.140 | 0.140 | 0.000 |
Preferred | 0.220 | 0.220 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 10.575 | 13.729 |
Price to Book | 0.730 | 1.868 |
Price to Sales | 0.426 | 2.378 |
Price to Cash Flow | 6.292 | 227.198 |
Dividend Yield | 6.260 | 8.117 |
5 Years Earnings Growth | 4.382 | 13.646 |
Name | Net % | Category Average |
---|---|---|
Derivative | -0.776 | 37.242 |
Corporate | 94.006 | 57.723 |
Government | 12.486 | 46.963 |
Cash | -5.860 | 24.925 |
Number of long holdings: 485
Number of short holdings: 120
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
2 Year Treasury Note Future Mar 25 | - | 5.80 | - | - | |
Us 5 Year Treasury Notes March 2015 | - | 2.63 | - | - | |
Us 10 Year Treasury Notes March 2015 | - | 2.08 | - | - | |
Telia Company AB 2.75% | XS2443749648 | 1.23 | - | - | |
Hologic Inc 3.25% | - | 0.94 | - | - | |
Euro Bund Future Dec 24 | DE000F0Q7BU6 | 0.88 | - | - | |
ASR Nederland N.V. 4.625% | XS1700709683 | 0.86 | - | - | |
Axa SA 6.375% | XS2737652474 | 0.83 | - | - | |
Euro Bobl Future Dec 24 | DE000F0Q7BV4 | 0.78 | - | - | |
Allianz SE 3.2% | - | 0.73 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SEB Dynamic Bond Fund C SEK | 20.74B | 7.58 | 2.71 | 1.24 | ||
SEB Dynamic Bond Fund IC SEK | 20.74B | 8.06 | 3.01 | 1.57 | ||
SEB Dynamic Bond Fund ID SEK | 20.74B | 7.71 | 2.67 | 1.17 | ||
SEB Dynamic Bond Fund HNW D SEK | 20.74B | 7.65 | 2.80 | 1.38 | ||
SEB Dynamic Bond Fund HNW C SEK | 20.74B | 7.65 | 2.80 | 1.38 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review